<code id='AE58FA363E'></code><style id='AE58FA363E'></style>
    • <acronym id='AE58FA363E'></acronym>
      <center id='AE58FA363E'><center id='AE58FA363E'><tfoot id='AE58FA363E'></tfoot></center><abbr id='AE58FA363E'><dir id='AE58FA363E'><tfoot id='AE58FA363E'></tfoot><noframes id='AE58FA363E'>

    • <optgroup id='AE58FA363E'><strike id='AE58FA363E'><sup id='AE58FA363E'></sup></strike><code id='AE58FA363E'></code></optgroup>
        1. <b id='AE58FA363E'><label id='AE58FA363E'><select id='AE58FA363E'><dt id='AE58FA363E'><span id='AE58FA363E'></span></dt></select></label></b><u id='AE58FA363E'></u>
          <i id='AE58FA363E'><strike id='AE58FA363E'><tt id='AE58FA363E'><pre id='AE58FA363E'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:2759
          Beth Israel Deaconess Medical Center in Boston
          David L. Ryan/The Boston Globe

          Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry.

          While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.

          advertisement

          Industry leaders are calling for urgent action from the Healey administration and the Legislature to help stem the crisis. Even just simplifying the state regulatory bureaucracy and approvals for bringing uninsured patients into the MassHealth system would help, executives say.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots
          STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

          NovoNordiskviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnew

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

          RogelioV.Solis/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne